216 related articles for article (PubMed ID: 9165573)
21. Presumed radically treated renal cell carcinoma--recurrence of the disease and prognostic factors for subsequent survival.
Beisland C; Medby PC; Beisland HO
Scand J Urol Nephrol; 2004; 38(4):299-305. PubMed ID: 15669589
[TBL] [Abstract][Full Text] [Related]
22. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
[TBL] [Abstract][Full Text] [Related]
23. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
[TBL] [Abstract][Full Text] [Related]
24. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
[TBL] [Abstract][Full Text] [Related]
25. Microvascular tumour invasion in renal cell carcinoma: the most important prognostic factor.
Dall'Oglio MF; Antunes AA; Sarkis AS; Crippa A; Leite KR; Lucon AM; Srougi M
BJU Int; 2007 Sep; 100(3):552-5. PubMed ID: 17555475
[TBL] [Abstract][Full Text] [Related]
26. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery.
Butler BP; Novick AC; Miller DP; Campbell SA; Licht MR
Urology; 1995 Jan; 45(1):34-40; discussion 40-1. PubMed ID: 7817478
[TBL] [Abstract][Full Text] [Related]
27. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.
Lau WK; Blute ML; Weaver AL; Torres VE; Zincke H
Mayo Clin Proc; 2000 Dec; 75(12):1236-42. PubMed ID: 11126830
[TBL] [Abstract][Full Text] [Related]
28. Capsular involvement in patients undergoing partial nephrectomy for localized renal cell carcinoma: an adverse pathological finding?
Rouach Y; Delongchamps N; Timsit MO; Verkarre V; Fontaine E; Peyromaure M; Mejean A
BJU Int; 2010 Mar; 105(5):616-9. PubMed ID: 19681891
[TBL] [Abstract][Full Text] [Related]
29. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
30. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
31. Nephron-sparing surgery for renal cell carcinoma--long-term results.
Lundstam S; Jonsson O; Lyrdal D; Peeker R; Pettersson S
Scand J Urol Nephrol; 2003; 37(4):299-304. PubMed ID: 12944187
[TBL] [Abstract][Full Text] [Related]
32. Enucleoresection for the elective treatment of small renal cell carcinoma: can it be the treatment of choice?
Adamakis I; Koutalellis G; Mitropoulos D; Vourekas S; Constantinides C; Zervas A
Onkologie; 2007 Mar; 30(3):97-102. PubMed ID: 17341895
[TBL] [Abstract][Full Text] [Related]
33. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
[TBL] [Abstract][Full Text] [Related]
34. [Partial nephrectomy for renal cell carcinoma using a microwave tissue coagulator--postoperative recurrence and renal function].
Fujimoto K; Tanaka N; Hirao Y
Hinyokika Kiyo; 2005 Aug; 51(8):511-5. PubMed ID: 16164265
[TBL] [Abstract][Full Text] [Related]
35. Enucleation of renal cell carcinoma with ablation of the tumour base.
Kutikov A; Vanarsdalen KN; Gershman B; Fossett LK; Guzzo TJ; Wein AJ; Malkowicz SB
BJU Int; 2008 Sep; 102(6):688-91. PubMed ID: 18384627
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma.
Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
[TBL] [Abstract][Full Text] [Related]
37. Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma.
Di Silverio F; Casale P; Colella D; Andrea L; Seccareccia F; Sciarra A
Cancer; 2000 Feb; 88(4):835-43. PubMed ID: 10679653
[TBL] [Abstract][Full Text] [Related]
38. The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases.
Zhang C; Li X; Hao H; Yu W; He Z; Zhou L
BJU Int; 2012 Dec; 110(11 Pt B):E481-5. PubMed ID: 22540142
[TBL] [Abstract][Full Text] [Related]
39. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
[TBL] [Abstract][Full Text] [Related]
40. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
Ishimura T; Sakai I; Hara I; Eto H; Miyake H
Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
